Evidence map›Paper›PMID 33747893›Full record

ArticleFrontiers in oncology2020

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy.

Li-Xiang Zhang, Pan-Quan Luo, Lei Chen, Dong-da Song, A-Man Xu, Peng Xu, Jia Xu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li-Xiang ZhangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Pan-Quan LuoDepartment of General Surgery, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.
Lei ChenDepartment of General Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Dong-da SongOncology Department, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
A-Man XuDepartment of General Surgery, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.
Peng XuDepartment of General Surgery, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.
Jia XuOncology Department, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognosis of patients with hepatocellular carcinoma (HCC) remains difficult to accurately predict. The purpose of this study was to establish a prognostic model for HCC based on a novel scoring system.

methodsFive hundred and sixty patients who underwent a curative hepatectomy for treatment of HCC at our hospital between January 2007 and January 2014 were included in this study. Univariate and multivariate analyses were used to screen for prognostic risk factors. The nomogram construction was based on Cox proportional hazard regression models, and the development of the new scoring model was analyzed using receiver operating characteristic (ROC) curve analysis and then compared with other clinical indexes. The novel scoring system was then validated with an external dataset from a different medical institution.

resultsMultivariate analysis showed that tumor size, portal vein tumor thrombus (PVTT), invasion of adjacent tissues, microvascular invasion, and levels of fibrinogen and total bilirubin were independent prognostic factors. The new scoring model had higher area under the curve (AUC) values compared to other systems, and the C-index of the nomogram was highly consistent for evaluating the survival of HCC patients in the validation and training datasets, as well as the external validation dataset.

conclusionsBased on serum markers and other clinical indicators, a precise model to predict the prognosis of patients with HCC was developed. This novel scoring system can be an effective tool for both surgeons and patients.

Indexed as

hepatocellular carcinomamodelnomogramoverall survivalprognosis

Identifiers

PMID33747893
PMCPMC7977285

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.